Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 8, Issue 3, 2003, Pages 179-186

  Galperín, Jorge ^a,f   Elizari, Marcelo V ^b   Chiale, Pablo A ^b   Molina, Remberto Torres ^b   Ledesma, Raúl ^c   Scapín, Angel O ^d   Blanco, Manuel Vázquez ^e   Bonato, Ricardo ^b   Lago, Manuel ^b  

^a HOSPITAL DURAND   (Argentina)

^b HOSPITAL RAMOS MEJÍA   (Argentina)

^c Instituto Del Corazon   (Argentina)

^d Grp Estud Multictr Argentinos   (Argentina)

^e HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^f NONE   (Argentina)

Author keywords

Antiarrhythmic drugs; Arrhythmia; Cardioversion

Indexed keywords

AMIODARONE;

ADULT; AGED; ARTICLE; BRADYCARDIA; BRONCHOSPASM; CARDIOVERSION; CONTROLLED STUDY; DISEASE DURATION; ENZYME BLOOD LEVEL; EYE DISEASE; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART VENTRICLE SIZE; HEPATOMEGALY; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; INTERSTITIAL PNEUMONIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; SINUS RHYTHM; THYROID DISEASE; TREATMENT OUTCOME; TREATMENT WITHDRAWAL;

EID: 0141522496     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840300800302     Document Type: Article

References (20)

1. Kochiadakis GE, Igoumenidis NE, Solomou MC, et al. Efficacy of amiodarone for the termination of persistent atrial fibrillation. Am J Cardiol 83(1):58-61, 1999
2. Roy D, Talajic M, Dorian P, et al. Amiodarone to prevent recurrence of atrial fibrillation. N Engl J Med 342:913-920, 2000
3. Galperin J, Elizari MV, Chiale PA, et al. Efficacy of amiodarone for the termination of chronic atrial fibrillation and maintenance of normal sinus rhythm: A prospective, multicenter, randomized, controlled, double blind trial. J Cardiovasc Pharmacol Therapeut 6(4):341-350, 2001
4. Duytschaever M, Haerynck F, Tavernier R, et al. Factors influencing long term persistence of sinus rhythm after a first electrical cardioversion for atrial fibrillation. Pacing Clin Electrophysiol 21(Part II):284-287, 1998
5. Ortiz de Murua JA, Avila MC, Ochoa C, et al. Independent predictive factors of acute and first year success after electrical cardioversion in patients with chronic atrial fibrillation. Rev Esp Cardiol 54:958-964, 2001
6. Brodsky MA, Allen BJ, Capparelli EV, et al. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilation. Am J Cardiol 63:1065-1068, 1989
7. Dethy M, Chassat C, Roy D, et al. Doppler echocardiographic predictors of recurrence of atrial fibrillation after cardioversion. Am J Cardiol 62:723-726, 1988
8. Abi-Samra FM, Feng Z, Davison N. Factors influencing long term maintenance of sinus rhythm after current cardioversion of atrial fibrillation. Europace Supplements 3:127/1, 2002
9. Van Gelder IC, Crijns HJ, Tieleman RG, et al. Chronic atrial fibrillation. Success of serial cardioversion therapy and safety of oral anticoagulation. Arch Intern Med 156(22):2585-2592, 1996
10. Crijns HJ, Van Gelder IC, Van Gilst, et al. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter. Am J Cardiol 68(4):335-341, 1991
11. Perez Y, Duval AM, Carville C, et al. Facteurs échographiques prédictifs du maintien du rythme sinusal un an apres cardioversion pour trouble du rythme auriculaire non valvulaire. Arch Mal Coeur 90:911-918, 1997
12. Maounis T, Kyrozi E, Katsaros K, et al. The prognostic significance of atrial arrhythmias recorded early after cardioversion for atrial fibrillation. Pacing Clin Electrophysiol 24:1076-1081, 2001
13. Flaker GC, Fletcher KA, Rothbart RM, et al. Clinical and echocardiographic features of intermittent atrial fibrillation that predict recurrent atrial fibrillation. Am J Cardiol 76:355-358, 1995
14. Alt E, Ammer R, Lehmann G, et al. Patients characteristics and underlying heart disease as predictors of recurrent atrial fibrillation after internal and external cardioversion in patients treated with oral sotalol. Am Heart J 134:419-425, 1997
15. Dittrich HC, Erickson JS, Schneiderman T, et al. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation. Am J Cardiol 63:193-197, 1989
16. Van Gelder IC, Tuinenburg AE, Schoonderwoerd BS, et al. Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation. Am J Cardiol 84(9A):147R-151R, 1999
17. Opolski G, Stanislawska J, Gorecki A, et al. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion. Clin Cardiol 20:337-340, 1997
18. Rebollo JMG, Madrid AH, Bueno MG. Predictors of pharmacologic reversion of persistent atrial fibrillation reversion with amiodarone. Europace Supplements 3:A188. 160PW/16, 2002
19. Deedwania PC, Singh BN, Ellenbogen K, et al. Spontaneous conversion and maintenance of sinus rhythm by amiodarone in patients with heart failure and atrial fibrillation. Circulation 98:2574-2579, 1998
20. Lumer GB, Roy D, Talajic M, et al. Amiodarone reduces procedures and costs related to atrial fibrillation in a controlled clinical trial. Eur Heart J 23:1050-1056, 2002